Multidrug-resistant Acinetobacter baumannii pneumonia in lung transplant recipients.
June 29th, 2008 | by admin |Multidrug-resistant Acinetobacter baumannii pneumonia in lung transplant recipients.
We present 6 cases of multidrug-resistant (MDR) Acinetobacter baumannii pneumonia in lung transplant recipients. All cases were treated with imipenem and/or non-traditional antibiotics, such as tigecycline and colistimethate, and had different microbiologic and clinical outcomes. Prior treatment with broad-spectrum anti-microbial therapy was the single most likely risk factor for the development of infection due to MDR Acinetobacter baumannii. Ideal preventive and therapeutic strategies for this pathogen in lung transplant recipients require further study.
Sopirala MM, Pope-Harman A, Nunley DR, Moffatt-Bruce S, Ross P, Martin SI.
Department of Internal Medicine, Division of Infectious Diseases, The Ohio State University Medical Center, Columbus, OH 43210, USA. madhuri.sopirala@osumc.edu